SDT Molecular, led by Shirley and her team, aims to be a leading provider of Total Diagnostic Solutions, delivering high-quality products and services in clinical diagnostics. Certified for GDPMDS and compliant with HSA and MOH Biosafety standards, the company specializes in diagnostic assays, quality controls, automation, rapid tests, and consultancy. Representing 18 global brands, SDT Molecular serves hospitals, laboratories, and government agencies. Expanding into Southeast Asia, it will establish its first overseas office in Hong Kong in 2023.
SDT Molecular, led by Shirley and her team, aims to be a leading provider of Total Diagnostic Solutions, delivering high-quality products and services in clinical diagnostics. Certified for GDPMDS and compliant with HSA and MOH Biosafety standards, the company specializes in diagnostic assays, quality controls, automation, rapid tests, and consultancy. Representing 18 global brands, SDT Molecular serves hospitals, laboratories, and government agencies. Expanding into Southeast Asia, it will establish its first overseas office in Hong Kong in 2023.
SDT Molecular, led by Shirley and her team, aims to be a leading provider of Total Diagnostic Solutions, delivering high-quality products and services in clinical diagnostics. Certified for GDPMDS and compliant with HSA and MOH Biosafety standards, the company specializes in diagnostic assays, quality controls, automation, rapid tests, and consultancy. Representing 18 global brands, SDT Molecular serves hospitals, laboratories, and government agencies. Expanding into Southeast Asia, it will establish its first overseas office in Hong Kong in 2023.